Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Dogwood Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +3 vs. Q3 2021
- Shares held
- 949.3K
- −53.6K (−5.3%) vs. Q3 2021
- Total value
- $4.85M
- −$451.0K (−8.5%) vs. Q3 2021
- New holders
- 6
- 3 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Masters Capital Management LLC | 650,000 | $3.33M | 0.59% | 00.0% | Unchanged |
| Vanguard Group Inc | 147,866 | $757.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 40,145 | $205.0K | 0.00% | 00.0% | Unchanged |
| Cetera Advisors LLC | 36,010 | $184.0K | 0.00% | −12,422−25.6% | Reduced |
| Geode Capital Management, LLC | 22,564 | $115.0K | 0.00% | +2,135+10.5% | Added |
| BlackRock Inc. | 18,641 | $95.0K | 0.00% | +2,785+17.6% | Added |
| Northern Trust Corp | 15,117 | $77.0K | 0.00% | +15,117 | New |
| Two Sigma Advisers, LP | 14,500 | $74.0K | 0.00% | −13,900−48.9% | Reduced |
| UBS Group AG | 2,250 | $12.0K | 0.00% | +2,250 | New |
| Advisor Group Holdings, Inc. | 1,851 | $9.00K | 0.00% | +43+2.4% | Added |
| Tevis Investment Management | 75 | $1.00K | 0.00% | +75 | New |
| Tower Research Capital LLC (TRC) | 30 | $0 | 0.00% | −2,373−98.8% | Reduced |
| Wells Fargo & Company | 45 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8 | $0 | 0.00% | +8 | New |
| Simplex Trading, LLC | 185 | $0 | 0.00% | +185 | New |
| Wolff Wiese Magana LLC | 52 | $0 | 0.00% | +52 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,781−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −17,776−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |